vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and FLOTEK INDUSTRIES INC (FTK). Click either name above to swap in a different company.

FLOTEK INDUSTRIES INC is the larger business by last-quarter revenue ($70.1M vs $38.9M, roughly 1.8× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 6.7%, a 18.0% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 27.0%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 23.2%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Flotek Industries Inc. is a technology-driven diversified company that develops and supplies specialty chemicals, performance materials and related equipment solutions for global energy, mining and industrial manufacturing sectors, delivering innovative sustainable products to boost client operational efficiency.

CDXS vs FTK — Head-to-Head

Bigger by revenue
FTK
FTK
1.8× larger
FTK
$70.1M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+54.3% gap
CDXS
81.3%
27.0%
FTK
Higher net margin
CDXS
CDXS
18.0% more per $
CDXS
24.7%
6.7%
FTK
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
23.2%
FTK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDXS
CDXS
FTK
FTK
Revenue
$38.9M
$70.1M
Net Profit
$9.6M
$4.7M
Gross Margin
94.8%
22.2%
Operating Margin
27.1%
10.8%
Net Margin
24.7%
6.7%
Revenue YoY
81.3%
27.0%
Net Profit YoY
192.5%
EPS (diluted)
$0.13
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
FTK
FTK
Q1 26
$70.1M
Q4 25
$38.9M
$67.5M
Q3 25
$8.6M
$56.0M
Q2 25
$15.3M
$58.4M
Q1 25
$7.5M
$55.4M
Q4 24
$21.5M
$50.8M
Q3 24
$12.8M
$49.7M
Q2 24
$8.0M
$46.2M
Net Profit
CDXS
CDXS
FTK
FTK
Q1 26
$4.7M
Q4 25
$9.6M
$3.0M
Q3 25
$-19.6M
$20.4M
Q2 25
$-13.3M
$1.8M
Q1 25
$-20.7M
$5.4M
Q4 24
$-10.4M
$4.4M
Q3 24
$-20.6M
$2.5M
Q2 24
$-22.8M
$2.0M
Gross Margin
CDXS
CDXS
FTK
FTK
Q1 26
22.2%
Q4 25
94.8%
22.5%
Q3 25
71.3%
31.7%
Q2 25
86.3%
24.7%
Q1 25
63.8%
22.5%
Q4 24
83.0%
24.2%
Q3 24
66.4%
18.3%
Q2 24
56.6%
19.9%
Operating Margin
CDXS
CDXS
FTK
FTK
Q1 26
10.8%
Q4 25
27.1%
8.9%
Q3 25
-220.3%
16.2%
Q2 25
-83.9%
4.4%
Q1 25
-271.6%
10.1%
Q4 24
-34.2%
10.1%
Q3 24
-129.0%
5.5%
Q2 24
-284.9%
4.8%
Net Margin
CDXS
CDXS
FTK
FTK
Q1 26
6.7%
Q4 25
24.7%
4.5%
Q3 25
-228.1%
36.3%
Q2 25
-86.6%
3.0%
Q1 25
-274.3%
9.7%
Q4 24
-48.4%
8.7%
Q3 24
-160.8%
5.1%
Q2 24
-285.2%
4.3%
EPS (diluted)
CDXS
CDXS
FTK
FTK
Q1 26
$0.12
Q4 25
$0.13
$0.09
Q3 25
$-0.22
$0.53
Q2 25
$-0.16
$0.05
Q1 25
$-0.25
$0.17
Q4 24
$-0.12
$0.15
Q3 24
$-0.29
$0.08
Q2 24
$-0.32
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
FTK
FTK
Cash + ST InvestmentsLiquidity on hand
$78.2M
$5.7M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$118.2M
Total Assets
$147.8M
$231.8M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
FTK
FTK
Q1 26
$5.7M
Q4 25
$78.2M
$5.7M
Q3 25
$58.7M
$4.6M
Q2 25
$66.3M
$5.0M
Q1 25
$59.8M
$6.3M
Q4 24
$73.5M
$4.4M
Q3 24
$90.3M
$5.0M
Q2 24
$73.2M
$4.8M
Total Debt
CDXS
CDXS
FTK
FTK
Q1 26
Q4 25
$40.1M
$40.0M
Q3 25
$39.7M
$40.0M
Q2 25
$39.4M
$40.0M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Stockholders' Equity
CDXS
CDXS
FTK
FTK
Q1 26
$118.2M
Q4 25
$50.5M
$113.1M
Q3 25
$38.5M
$110.5M
Q2 25
$55.6M
$71.8M
Q1 25
$49.6M
$119.7M
Q4 24
$66.9M
$113.9M
Q3 24
$73.4M
$109.0M
Q2 24
$61.4M
$106.2M
Total Assets
CDXS
CDXS
FTK
FTK
Q1 26
$231.8M
Q4 25
$147.8M
$220.0M
Q3 25
$124.0M
$212.7M
Q2 25
$138.2M
$172.2M
Q1 25
$128.9M
$170.2M
Q4 24
$149.0M
$170.8M
Q3 24
$148.2M
$160.6M
Q2 24
$132.0M
$156.0M
Debt / Equity
CDXS
CDXS
FTK
FTK
Q1 26
Q4 25
0.79×
0.35×
Q3 25
1.03×
0.36×
Q2 25
0.71×
0.56×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
FTK
FTK
Operating Cash FlowLast quarter
$20.1M
$21.0K
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
1.4%
Cash ConversionOCF / Net Profit
2.09×
0.00×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
FTK
FTK
Q1 26
$21.0K
Q4 25
$20.1M
$6.2M
Q3 25
$-7.7M
$-1.9M
Q2 25
$-18.0M
$-4.5M
Q1 25
$-13.8M
$7.3M
Q4 24
$-16.5M
$-2.6M
Q3 24
$-13.0M
$5.1M
Q2 24
$-12.2M
$-3.1M
Free Cash Flow
CDXS
CDXS
FTK
FTK
Q1 26
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
FCF Margin
CDXS
CDXS
FTK
FTK
Q1 26
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Capex Intensity
CDXS
CDXS
FTK
FTK
Q1 26
1.4%
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Cash Conversion
CDXS
CDXS
FTK
FTK
Q1 26
0.00×
Q4 25
2.09×
2.07×
Q3 25
-0.09×
Q2 25
-2.54×
Q1 25
1.36×
Q4 24
-0.58×
Q3 24
2.01×
Q2 24
-1.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDXS
CDXS

Segment breakdown not available.

FTK
FTK

Revenue from related party$51.9M74%
Revenue from external customers$18.2M26%

Related Comparisons